BMJ · 2019 · 211 citations · 16 references
MedicinePharmacologyPharmacotherapyChemotherapyClinical PharmacologyDrug LawCannabinoid PharmacologyCannabis RegulationDrugs Of AbusePharmacoepidemiologyAdverse Effects Of CannabinoidsIllicit Synthetic CannabinoidsMedicinal UsesSerious Adverse EventsSynthetic Cannabinoid IntoxicationTherapeutic Cannabinoid UseTreatment-resistant EpilepsyUnlicensed Spectrum
Cannabis based products for medicinal use contain cannabinoids derived from the cannabis plant, including 9 -tetrahydrocannabinol (THC), cannabidiol (CBD), or a combination of THC and CBD. Synthetic cannabinoids for medicinal use typically mimic the effects of specific cannabinoids such as THC
16